Cescato R - Search Results

1

Upregulation of Key Molecules for Targeted Imaging and Therapy.

Taelman VF, Radojewski P, Marincek N, Ben-Shlomo A, Grotzky A, Olariu CI, Perren A, Stettler C, Krause T, Meier LP, Cescato R, Walter MA. Taelman VF, et al. Among authors: cescato r. J Nucl Med. 2016 Nov;57(11):1805-1810. doi: 10.2967/jnumed.115.165092. Epub 2016 Jun 30. J Nucl Med. 2016. PMID: 27363833 Free article.

2

Internalized somatostatin receptor subtype 2 in neuroendocrine tumors of octreotide-treated patients.

Reubi JC, Waser B, Cescato R, Gloor B, Stettler C, Christ E. Reubi JC, et al. Among authors: cescato r. J Clin Endocrinol Metab. 2010 May;95(5):2343-50. doi: 10.1210/jc.2009-2487. Epub 2010 Mar 12. J Clin Endocrinol Metab. 2010. PMID: 20228164 Free PMC article.

3

Radiolabeled bicyclic somatostatin-based analogs: a novel class of potential radiotracers for SPECT/PET of neuroendocrine tumors.

Fani M, Mueller A, Tamma ML, Nicolas G, Rink HR, Cescato R, Reubi JC, Maecke HR. Fani M, et al. Among authors: cescato r. J Nucl Med. 2010 Nov;51(11):1771-9. doi: 10.2967/jnumed.110.076695. Epub 2010 Oct 18. J Nucl Med. 2010. PMID: 20956465 Free article.

4

Highly efficient in vivo agonist-induced internalization of sst2 receptors in somatostatin target tissues.

Waser B, Tamma ML, Cescato R, Maecke HR, Reubi JC. Waser B, et al. Among authors: cescato r. J Nucl Med. 2009 Jun;50(6):936-41. doi: 10.2967/jnumed.108.061457. Epub 2009 May 14. J Nucl Med. 2009. PMID: 19443580 Free article.

5

Unexpected sensitivity of sst2 antagonists to N-terminal radiometal modifications.

Fani M, Braun F, Waser B, Beetschen K, Cescato R, Erchegyi J, Rivier JE, Weber WA, Maecke HR, Reubi JC. Fani M, et al. Among authors: cescato r. J Nucl Med. 2012 Sep;53(9):1481-9. doi: 10.2967/jnumed.112.102764. Epub 2012 Jul 31. J Nucl Med. 2012. PMID: 22851637 Free article.

6

Bombesin receptor antagonists may be preferable to agonists for tumor targeting.

Cescato R, Maina T, Nock B, Nikolopoulou A, Charalambidis D, Piccand V, Reubi JC. Cescato R, et al. J Nucl Med. 2008 Feb;49(2):318-26. doi: 10.2967/jnumed.107.045054. Epub 2008 Jan 16. J Nucl Med. 2008. PMID: 18199616 Free article.

7

PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference.

Fani M, Del Pozzo L, Abiraj K, Mansi R, Tamma ML, Cescato R, Waser B, Weber WA, Reubi JC, Maecke HR. Fani M, et al. Among authors: cescato r. J Nucl Med. 2011 Jul;52(7):1110-8. doi: 10.2967/jnumed.111.087999. Epub 2011 Jun 16. J Nucl Med. 2011. PMID: 21680701 Free article.

8

Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists.

Cescato R, Schulz S, Waser B, Eltschinger V, Rivier JE, Wester HJ, Culler M, Ginj M, Liu Q, Schonbrunn A, Reubi JC. Cescato R, et al. J Nucl Med. 2006 Mar;47(3):502-11. J Nucl Med. 2006. PMID: 16513620 Free article.

9

Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumors.

Abiraj K, Mansi R, Tamma ML, Fani M, Forrer F, Nicolas G, Cescato R, Reubi JC, Maecke HR. Abiraj K, et al. Among authors: cescato r. J Nucl Med. 2011 Dec;52(12):1970-8. doi: 10.2967/jnumed.111.094375. Epub 2011 Nov 11. J Nucl Med. 2011. PMID: 22080443 Free article.

10

Evaluation of 177Lu-DOTA-sst2 antagonist versus 177Lu-DOTA-sst2 agonist binding in human cancers in vitro.

Cescato R, Waser B, Fani M, Reubi JC. Cescato R, et al. J Nucl Med. 2011 Dec;52(12):1886-90. doi: 10.2967/jnumed.111.095778. Epub 2011 Nov 8. J Nucl Med. 2011. PMID: 22068898 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters